Cell Reports Medicine
  • 数据库收录SCIE
  • 创刊年份2020年
  • 年发文量305

Cell Reports Medicine

期刊中文名:细胞医学报道ISSN:2666-3791E-ISSN:2666-3791

该杂志国际简称:Cell Rep Med,是由出版商Elsevier出版的一本致力于发布医学研究新成果的的专业学术期刊。该杂志以MEDICINE, RESEARCH & EXPERIMENTAL研究为重点,主要发表刊登有创见的学术论文文章、行业最新科研成果,扼要报道阶段性研究成果和重要研究工作的最新进展,选载对学科发展起指导作用的综述与专论,促进学术发展,为广大读者服务。该刊是一本国际优秀杂志,在国际上有很高的学术影响力。

基本信息:
期刊简称:Cell Rep Med
是否OA:开放
是否预警:
Gold OA文章占比:93.57%
出版信息:
出版地区:United States
出版周期:Monthly
出版语言:English
出版商:Elsevier
评价信息:
中科院分区:1区
JCR分区:Q1
影响因子:11.7
CiteScore:15
投稿咨询 加急咨询

发表咨询:400-888-7501

杂志介绍 中科院JCR分区 JCR分区 CiteScore 投稿经验

杂志介绍

Cell Reports Medicine杂志介绍

《Cell Reports Medicine》是一本以English为主的开放获取国际优秀期刊,中文名称细胞医学报道,本刊主要出版、报道医学-MEDICINE, RESEARCH & EXPERIMENTAL领域的研究动态以及在该领域取得的各方面的经验和科研成果,介绍该领域有关本专业的最新进展,探讨行业发展的思路和方法,以促进学术信息交流,提高行业发展。该刊已被国际权威数据库SCIE收录,为该领域相关学科的发展起到了良好的推动作用,也得到了本专业人员的广泛认可。该刊最新影响因子为11.7,最新CiteScore 指数为15。

本刊近期中国学者发表的论文主要有:

  • Current understanding of the intratumoral microbiome in various tumors

    Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan

  • Inherited mutations in Chinese patients with upper tract urothelial carcinoma

    Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei

  • Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases

    Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan

  • Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET

    Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao

英文介绍

Cell Reports Medicine杂志英文介绍

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

中科院SCI分区

Cell Reports Medicine杂志中科院分区信息

2023年12月升级版
综述:
TOP期刊:
大类:医学 1区
小类:

MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验 1区

CELL BIOLOGY
细胞生物学 2区

2022年12月升级版
综述:
TOP期刊:
大类:医学 1区
小类:

MEDICINE, RESEARCH & EXPERIMENTAL
医学:研究与实验 1区

CELL BIOLOGY
细胞生物学 2区

中科院SCI分区:是中国科学院文献情报中心科学计量中心的科学研究成果。期刊分区表自2004年开始发布,延续至今;2019年推出升级版,实现基础版、升级版并存过渡,2022年只发布升级版,期刊分区表数据每年底发布。 中科院分区为4个区。中科院分区采用刊物前3年影响因子平均值进行分区,即前5%为该类1区,6%~20%为2区、21%~50%为3区,其余的为4区。1区和2区杂志很少,杂志质量相对也高,基本都是本领域的顶级期刊。

JCR分区(2023-2024年最新版)

Cell Reports Medicine杂志 JCR分区信息

按JIF指标学科分区
学科:CELL BIOLOGY
收录子集:SCIE
分区:Q1
排名:22 / 205
百分位:

89.5%

学科:MEDICINE, RESEARCH & EXPERIMENTAL
收录子集:SCIE
分区:Q1
排名:10 / 189
百分位:

95%

按JCI指标学科分区
学科:CELL BIOLOGY
收录子集:SCIE
分区:Q1
排名:14 / 205
百分位:

93.41%

学科:MEDICINE, RESEARCH & EXPERIMENTAL
收录子集:SCIE
分区:Q1
排名:8 / 189
百分位:

96.03%

JCR分区:JCR分区来自科睿唯安公司,JCR是一个独特的多学科期刊评价工具,为唯一提供基于引文数据的统计信息的期刊评价资源。每年发布的JCR分区,设置了254个具体学科。JCR分区根据每个学科分类按照期刊当年的影响因子高低将期刊平均分为4个区,分别为Q1、Q2、Q3和Q4,各占25%。JCR分区中期刊的数量是均匀分为四个部分的。

CiteScore 评价数据(2024年最新版)

Cell Reports Medicine杂志CiteScore 评价数据

  • CiteScore 值:15
  • SJR:4.276
  • SNIP:1.664
学科类别 分区 排名 百分位
大类:Medicine 小类:General Medicine Q1 25 / 636

96%

大类:Medicine 小类:General Biochemistry, Genetics and Molecular Biology Q1 18 / 221

92%

历年影响因子和期刊自引率

投稿经验

Cell Reports Medicine杂志投稿经验

该杂志是一本国际顶级杂志,在医学-MEDICINE, RESEARCH & EXPERIMENTAL学科领域中属于核心刊物,是能够综合反映该学科领域当前最高发展水平的学术期刊。在国际上有很高的学术影响力,行业关注度很高,已被国际权威数据库SCIE收录,该杂志在MEDICINE, RESEARCH & EXPERIMENTAL综合专业领域专业度认可很高,对稿件内容的创新性和学术性要求非常高,作为一本国际顶级杂志,一般投稿过审时间都较长,投稿过审时间平均约Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks ,如果想投稿该刊要做好时间安排。版面费不祥。该杂志近两年未被列入预警名单,建议您投稿。如您想了解更多投稿政策及投稿方案,请咨询客服。

免责声明

若用户需要出版服务,请联系出版商:ELSEVIER, RADARWEG 29, AMSTERDAM, Netherlands, 1043 NX。